Europe Veterinary Healthcare Market Growth, Size, Trends, Revenue, Demand and Future Outlook
Europe Veterinary Healthcare Market Size- By Product, By Animal Type- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Feb-2024 | Report ID: HLCA2422 | Pages: 1 - 159 | Formats*: |
| Category : Healthcare | |||
Europe Veterinary Healthcare Market Introduction and Overview
According to SPER Market Research, the Europe Veterinary Healthcare Market is estimated to reach USD 21.62 billion by 2033 with a CAGR of 7.8%.
The report includes an in-depth analysis of the Europe Veterinary Healthcare Market, including market size and trends, product mix, distribution channels, and supplier analysis. The term "veterinary healthcare" describes the medical attention and services given to animals, especially domestic pets and livestock, with the goal of ensuring their health and welfare. It covers a broad spectrum of procedures and therapies meant to avoid, identify, and manage diseases, wounds, and other medical issues in animals. Through routine vaccinations, parasite control, dental care, nutrition counseling, and wellness check-ups, it involves steps to prevent illnesses and maintain the general health of animals. Additionally, by addressing animal abuse or neglect, advocating for humane treatment, and guaranteeing the wellbeing of animals in various settings, veterinary healthcare professionals also play a critical role in promoting animal welfare.
- VolitionRx launched its Nu. Q Vet Cancer Screening Test in the United States and Europe in November 2022, using Heska's veterinary diagnostic laboratories as its global supply partner.
- The Livestock Vaccination Guideline was launched in May 2022 by the United Kingdom National Office of Animal Health (NOAH) to assist veterinarians and farmers in improving the health and welfare of sheep and cattle in the United Kingdom, as well as to support farm resilience and sustainable productivity improvements.
Market Opportunities and Challenges
Opportunities: The primary factor driving the European veterinary healthcare market is rising animal adoption in European countries, combined with increased government initiatives and improved animal healthcare. According to the Pet Food Manufacturers Association, 3.2 million UK households had acquired a pet since the pandemic began in 2021. The UK has 34 million pets, which include 12 million cats, 12 million dogs, 3.2 million small mammals such as guinea pigs and hamsters, 3 million birds, and 1.5 million reptiles. Furthermore, technological advancements in animal diagnostic technologies for accurate diagnostics, as well as increased penetration by some of the market's key and dominant players, are expected to drive market growth.
Challenges: Numerous issues affect the dynamics and general efficacy of the European veterinary healthcare market. The rising incidence of zoonotic illnesses, or infections spread from animals to humans, is one major problem. This calls for sophisticated and specialized care, placing pressure on veterinary healthcare systems to keep up with new illnesses and implement efficient preventative measures. Financial difficulties are also faced by pet owners and healthcare professionals due to the rising expense of veterinary care and the growing demand for pet insurance. Moreover, differences in standards, licensing, and approval procedures for veterinary medications and therapies are a result of regulatory complexities among European nations, which impedes the smooth integration of markets. The market's fragmented structure, which includes a large number of small and medium-sized businesses, presents additional difficulties for effective distribution networks and streamlined operations.
Market Competitive Landscape
The existence of multiple companies operating both globally and regionally has resulted in fragmentation within the European veterinary healthcare market. Among the well-known and market-share-holding companies analyzed in the competitive landscape are Abaxis Inc., Bayer AG, Benfield Pet Hospital, Boehringer Ingelheim International GmbH, Ceva Animal Health Inc., CVS Group, ECO Animal Health, Elanco, Greencross Vets, Idexx Laboratories, MSD Animal Health, The Bergh Memorial Animal Hospital, Vetoquinol UK Limited, Virbac, and Zoetis Animal Healthcare.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product, By Animal Type |
| Regions covered | Germany, United Kingdom, France, Italy, Spain, Rest of Europe |
| Companies Covered | Boehringer Ingelheim International GmbH, Ceva Sante Animale (CEVA), Dechra Pharmaceuticals PLC., Dopharma, ECO Animal Health Group Plc, Elanco, Hipra, Idexx Laboratories, Inc., Laboratorios Syva, MSD Animal Health, Norbrook, Orion Corporation, Vetoquinol S.A., Virbac, Others. |
COVID-19 Impact on Europe Veterinary Healthcare Market
The European pandemic caused supply chain disruptions and delays in the delivery of diagnostic equipment, consumables, and reagents, which initially had a negative effect on the market during COVID-19. The market faced a number of major challenges during a pandemic, such as port checkpoints and truck traffic jams that slowed down the delivery of essential supplies; several nations imposed export bans; and only a small number of manufacturing facilities were operational. Consequently, at first, these factors hindered the market's growth rate. Conversely, the pandemic's outbreak led to a rise in pet ownership in Spain, which helped the market expand.
Key Target Audience:
- Veterinarians and Veterinary Practitioners
- Pet Owners and Animal Enthusiasts
- Animal Farm Owners and Livestock Producers
- Pharmaceutical and Biotechnology Companies
- Retailers and Distributors
Our in-depth analysis of the Europe Veterinary Healthcare Market includes the following segments:
| By Product: |
|
| By Animal Type: |
|
| By Region: |
|
Key Topics Covered in the Report:
- Europe Veterinary Healthcare Market Size (FY’2023-FY’2033)
- Overview of Europe Veterinary Healthcare Market
- Segmentation of Europe Veterinary Healthcare Market By Product (Therapeutics, Diagnostics)
- Segmentation of Europe Veterinary Healthcare Market By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Others)
- Expansion Analysis of Europe Veterinary Healthcare Market
- Problems and Obstacles in Europe Veterinary Healthcare Market
- Competitive Landscape in the Europe Veterinary Healthcare Market
- Impact of COVID-19 and Demonetization on Europe Veterinary Healthcare Market
- Details on Current Investment in Europe Veterinary Healthcare Market
- Competitive Analysis of Europe Veterinary Healthcare Market
- Prominent Players in the Europe Veterinary Healthcare Market
- SWOT Analysis of Europe Veterinary Healthcare Market
- Europe Veterinary Healthcare Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Veterinary Healthcare Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Veterinary Healthcare Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Veterinary Healthcare Market
7. Europe Veterinary Healthcare Market, By Product (USD Million)
7.1. Europe Veterinary Healthcare Market Value Share and Forecast, By Product, 2023-20337.2. Therapeutics7.2.1. Vaccines7.2.2. Parasiticides7.2.3. Anti-infectives7.2.4. Medical Feed Additives7.2.5. Others7.3. Diagnostics7.3.1. Immunodiagnostic Tests7.3.2. Molecular Diagnostics7.3.3. Diagnostic Imaging7.3.4. Clinical Chemistry7.3.5. Others
8. Europe Veterinary Healthcare Market, By Animal Type (USD Million)
8.1. Europe Veterinary Healthcare Market Value Share and Forecast, By Animal Type, 2023-20338.2. Dogs and Cats8.3. Horses8.4. Ruminants8.5. Swine8.6. Poultry8.7. Others
9. Europe Veterinary Healthcare Market Forecast, 2019-2033 (USD Million)
9.1. Europe Veterinary Healthcare Market Size and Market Share
10. Europe Veterinary Healthcare Market, By Product, 2019-2033 (USD Million)
10.1. Europe Veterinary Healthcare Market Size and Market Share By Product (2019-2026)10.2. Europe Veterinary Healthcare Market Size and Market Share By Product (2027-2033)
11. Europe Veterinary Healthcare Market, By Animal Type, 2019-2033 (USD Million)
11.1. Europe Veterinary Healthcare Market Size and Market Share By Animal Type, (2019-2026)11.2. Europe Veterinary Healthcare Market Size and Market Share By Animal Type, (2027-2033)
12. Europe Veterinary Healthcare Market, By Region, 2019-2033 (USD Million)
12.1. Europe Veterinary Healthcare Market Size and Market Share By Region (2019-2026)12.2. Europe Veterinary Healthcare Market Size and Market Share By Region (2027-2033)12.3. Germany12.4. United Kingdom12.5. France12.6. Italy12.7. Spain12.8. Rest of Europe
13. Company Profile
13.1. Boehringer Ingelheim International GmbH13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments13.2. Ceva Sante Animale (CEVA)13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments13.3. Dechra Pharmaceuticals PLC.13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments13.4. Dopharma13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments13.5. ECO Animal Health Group Plc13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments13.6. Elanco13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments13.7. Hipra13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments13.8. Idexx Laboratories, Inc.13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments13.9. Laboratorios Syva13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments13.10. MSD Animal Health13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments13.11. Norbrook13.11.1. Company details13.11.2. Financial outlook13.11.3. Product summary13.11.4. Recent developments13.12. Orion Corporation13.12.1. Company details13.12.2. Financial outlook13.12.3. Product summary13.12.4. Recent developments13.13. Vetoquinol S.A.13.13.1. Company details13.13.2. Financial outlook13.13.3. Product summary13.13.4. Recent developments13.14. Virbac13.14.1. Company details13.14.2. Financial outlook13.14.3. Product summary13.14.4. Recent developments13.15. Others
14. Reference Links
15. Conclusion
16. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe Veterinary Healthcare Market is projected to reach USD 21.62 billion by 2033, growing at a CAGR of 7.8% during the forecast period.
Europe Veterinary Healthcare Market size from 2022. The Market is expected to reach USD 21.62 billion by 2033, at a CAGR of 7.8% during the forecast period.
Europe Veterinary Healthcare Market CAGR of 7.8% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Veterinary Healthcare Market size is 21.62 billion from 2023 to 2033.
Europe Veterinary Healthcare Market Segment is covered By Product, By Animal Type.
The Europe is anticipated to have the highest market share in the Europe Veterinary Healthcare Market.
"The key players in the market include Companies Covered Boehringer Ingelheim International GmbH, Ceva Sante Animale (CEVA), Dechra Pharmaceuticals PLC., Dopharma, ECO Animal Health Group Plc, Elanco, Hipra, Idexx Laboratories, Inc., Laboratorios Syva, MSD Animal Health, Norbrook, Orion Corporation, Vetoquinol S.A., Virbac, Others."
Furthermore, technological advancements in animal diagnostic technologies for accurate diagnostics, as well as increased penetration by some of the market's key and dominant players, are expected to drive market growth.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
